2016
DOI: 10.1016/j.toxicon.2016.06.018
|View full text |Cite
|
Sign up to set email alerts
|

Development of a chicken-derived antivenom against the taipan snake (Oxyuranus scutellatus) venom and comparison with an equine antivenom

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 52 publications
0
11
0
1
Order By: Relevance
“…Our method is more cost-effective than production of horse antivenom, which requires approximately 60 mg for two months. Previous studies also indicated that it is 30–40% less expensive to use chickens as an immunoglobulin source instead of horses [ 31 ]. Based on our results, a strong antibody response was elicited in chickens and lasted for at least six months according to Western blot ( Figure 1 A) and ELISA assays ( Figure 1 B,C).…”
Section: Discussionmentioning
confidence: 99%
“…Our method is more cost-effective than production of horse antivenom, which requires approximately 60 mg for two months. Previous studies also indicated that it is 30–40% less expensive to use chickens as an immunoglobulin source instead of horses [ 31 ]. Based on our results, a strong antibody response was elicited in chickens and lasted for at least six months according to Western blot ( Figure 1 A) and ELISA assays ( Figure 1 B,C).…”
Section: Discussionmentioning
confidence: 99%
“…However, IgY raised against the venom of the snake Oxyuranus scutellatus was less effective than equine IgG, being unable to neutralize the neurotoxic and coagulant effects of the venom [98]. Nonetheless, this result cannot be extended to IgY produced against other venoms.…”
Section: Anti-venom Activitymentioning
confidence: 92%
“…Other studies also concluded that the cost of antibody production was 30%-40% cheaper in hens than horses, especially in developing countries [46]. Numerous studies on IgY used for immunotherapy in clinical and experimental treatments have been reported [24,25].…”
Section: Discussionmentioning
confidence: 99%